Quadrant Capital Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$662K Buy
141,091
+52,824
+60% +$232K 0.02% 742
2026
Q2
$340K Buy
88,267
+87,696
+15,358% +$320K 0.01% 1045
2026
Q1
$2.26K Buy
+571
New +$2.88K ﹤0.01% 2489
2023
Q1
– Sell
-279
Closed -$776 – 2761
2022
Q4
$776 Buy
+279
New +$834 ﹤0.01% 2580
2018
Q2
– Sell
-198
Closed – – 2182
2018
Q1
$0 Buy
+198
New +$2.3K ﹤0.01% 2190
2016
Q2
– Sell
-673
Closed -$5K – 2032
2016
Q1
$5K Buy
+673
New +$5.59K ﹤0.01% 1164

Other funds holding MDXG

Quadrant Capital Group's MDXG Position: Q3 2026 in Review

Quadrant Capital Group increased its MiMedx Group (MDXG) stake by 60% in Q3 2026, buying an estimated $232K and bringing the position to 141,091 shares worth $662K. The position accounts for 0.02% of the portfolio, ranked #742.

Quadrant Capital Group first reported a position in MDXG in Q1 2016 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Quadrant Capital Group held 141,091 shares of MiMedx Group worth $662K as of Q3 2026.
  • Quadrant Capital Group bought 52,824 MiMedx Group shares in Q3 2026, an estimated $232K.
  • MiMedx Group made up 0.02% of Quadrant Capital Group's portfolio in Q3 2026, its #742 holding.
  • Quadrant Capital Group first reported a position in MiMedx Group in Q1 2016 and has held it in 6 quarters since.
  • 33 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.